The European Cancer and Oncology Congress, scheduled for April 14-15, 2025, in Rome, Italy, promises to be a pivotal event for professionals dedicated to advancing cancer research and treatment across Europe and beyond. This congress serves as a crucial platform for oncologists, researchers, clinicians, nurses, and allied healthcare professionals to exchange ideas, present cutting-edge research findings, and discuss the latest innovations in cancer diagnosis, treatment, and care.
Participants can expect a comprehensive program featuring keynote presentations by eminent experts in the field, informative symposia, workshops, and poster sessions showcasing groundbreaking research. The congress will cover a wide spectrum of topics including advances in personalized medicine, immunotherapy, novel treatment modalities, supportive care, survivorship, and the integration of digital health technologies in oncology practice.
Join us at the European Cancer and Oncology Congress 2025 in Rome to be part of this transformative event driving innovation and excellence in cancer research and clinical practice.
Abstract Submission Deadline: Nov 26, 2024
Early Bird Registration: Nov 29, 2024
Mid Term Registration: Dec 16, 2024
Final/Onsite Registration: Apr 14, 2025
Research Group Leader, Ludwig Boltzmann Institute for Rehabilitation Research
Austria
Department of Medical Oncology, Sir Runrun Shaw Hospital, Zhejiang University
China
Aakash Healthcare Superspeciality Hospital
India
Phoenicia Medical Centre PMC
Lebanon
University of the Witwatersrand
South africa
Ludwig Boltzmann for Rehabilitation Research
Austria
Laboratory for Hereditary Cancer, Division of Molecular Medicine, Ruđer Bošković Institute
Croatia
Department of Life Sciences, Pohang University of Science and Technology (POSTECH)
South korea
Dear colleagues:
It is our pleasure to invite you to the European Cancer and Oncology Congress 2015 in Rome. This meeting is a unique opportunity to enhance and deepen our knowledge on the latest achievements in all fields of clinical oncology as well as cancer research. It will also emphasize interprofessional and interdisciplinary contacts with all stakeholders. International speakers and an audience of researchers and medical, surgical and radiation oncologists, nurses, health care providers and administrators, and professionals from the industry will exchange new insights on the fight against cancer.
New inventions and constant optimization of all treatment options are the basis for successful treatment of cancer. Share your new data of experimental research and clinical trials or observations. We cordially invite you to submit your abstracts as oral talks or posters. Presentations will be possible both in presence and as an electronic contribution. We look forward to welcoming you in the historic and lively city of Rome in spring.
Best regards,
Professor. Thomas Licht
Research Group Leader, Ludwig Boltzmann Institute for Rehabilitation Research
Austria
Oncology Research is committed to publishing high-quality, innovative research that is focused on the entire range of basic, translational, and clinical cancer research, with a particular interest in cancer therapeutics, providing a new platform for the understanding, prevention, diagnosis, and treatment of cancer.
Indexing and Abstracting
Science Citation Index Expanded (Clarivate Analytics): 2023 Impact Factor: 2.0; Scopus CiteScore (Impact per Publication 2023): 4.4; SNIP (Source Normalized Impact per Paper 2023): 0.473; Embase; PubMed Central; MEDLINE; EBSCO; Google Scholar; Proquest; Portico, etc.